Democrats Set to Scale Back Drug-Price Ambitions in Biden’s Bill
- Tool to cut drug prices would exempt those with exclusivity
- Lawmakers seeking framework deal on social benefits package
This article is for subscribers only.
Democrats working on President Joe Biden’s big social-spending bill are discussing a proposal to limit the main tool for lowering drug prices to medicines that already face competition, people familiar with the talks said.
The White House proposal, viewed as an effort to win over holdout lawmakers including Senator Kyrsten Sinema, would exempt new drugs and many with the biggest price tags. The change would be a major shift away from earlier proposals that focused mostly on drugs that face no competition.